Found 5 matching trials
A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB N/A A Long-Term Extension Study for Participants Previously Treated with EB-101...
Show More Status
Enrolling By Invitation
Location
Stanford University
Learn More & Join Trial
A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial N/A This is an open-label follow up study to evaluate the safety for the subjec...
Show More Location
Gangnam Severence Hospital
Learn More & Join Trial
A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting N/A The goal of this observational study is to evaluate the long-term safety an...
Show More Location
Lucile Packard Children's Hospital
Learn More & Join Trial
Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) PHASE3 The purpose of this trial is to evaluate safety and efficacy of surgical ap...
Show More Location
Stanford University
Learn More & Join Trial
A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients PHASE3 To evaluate and further characterize the safety of EB-101 (LZRSE-Col7A1 gen...
Show More Status
Active Not Recruiting
Location
Stanford University
Learn More & Join Trial